Attendees discussed the need for quality, noting the industry has a long way to go.
Rule changes include mandating ORELAP to accredit laboratories, stricter sample collection rules and more comprehensive pesticide testing requirements.
Outside-industry guidance helps move the cannabis marketplace forward responsibly.
State legal protections and medical research should spur insurance companies to tackle cannabis.
Developing SOPs for cultivation practices and sales protocols help companies stay compliant.
The stigma associated with cannabis and its federal illegality prevent the normalization of cannabis business.
Recent reports of a $6 billion energy bill for the legal cannabis industry are misleading and incorrect.
Using the defense of deeming contracts void based on illegality in litigation could set dangerous precedents for the industry going forward.
Quality is not just tested for in the final product, but built into each step of the manufacturing process.
On their 42-acre farm, Jacques and his team are strain-testing and formulating customizable cannabis oils for individual patients.
